Pharmacokinetics of Clivarin a new low molecular weight heparin in healthy volunteers

The antithrombotic activity and pharmacokinetics of Clivarin®, a low molecular weight heparin was randomly studied in 10 healthy male volunteers. Doses of 20, 40, 60 and 80 anti F Xa U/kg BW were injected intravenously and subcutaneously in crossover fashion. The heparin concentrations were measured...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Andrassy, Konrad (VerfasserIn) , Eschenfelder, Volker (VerfasserIn) , Koderisch, Janti (VerfasserIn) , Weber, E. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 1994
In: Thrombosis research
Year: 1994, Jahrgang: 73, Heft: 2, Pages: 95-108
ISSN:1879-2472
DOI:10.1016/0049-3848(94)90084-1
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/0049-3848(94)90084-1
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/0049384894900841
Volltext
Verfasserangaben:K. Andrassy, V. Eschenfelder, J. Koderisch, E. Weber

MARC

LEADER 00000caa a2200000 c 4500
001 1860342248
003 DE-627
005 20240311163724.0
007 cr uuu---uuuuu
008 230927s1994 xx |||||o 00| ||eng c
024 7 |a 10.1016/0049-3848(94)90084-1  |2 doi 
035 |a (DE-627)1860342248 
035 |a (DE-599)KXP1860342248 
035 |a (OCoLC)1425897032 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Andrassy, Konrad  |e VerfasserIn  |0 (DE-588)1076338119  |0 (DE-627)834722216  |0 (DE-576)445217197  |4 aut 
245 1 0 |a Pharmacokinetics of Clivarin a new low molecular weight heparin in healthy volunteers  |c K. Andrassy, V. Eschenfelder, J. Koderisch, E. Weber 
264 1 |c 1994 
300 |a 14 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Elektronische Reproduktion der Druck-Ausgabe 9. April 2004 
500 |a Gesehen am 27.09.2023 
520 |a The antithrombotic activity and pharmacokinetics of Clivarin®, a low molecular weight heparin was randomly studied in 10 healthy male volunteers. Doses of 20, 40, 60 and 80 anti F Xa U/kg BW were injected intravenously and subcutaneously in crossover fashion. The heparin concentrations were measured by inhibition of clotting assays (anti Ila and anti Xa activities using amidolytic assays and (dilute) thrombin time. The pharmacokinetic profile of Clivarin® is characterized by a linear relationship between dose and absorption, relatively low clearance and a long elimination half-life, and a high anti Xa/anti Ila ratio of 5.3. 
650 4 |a heparin 
650 4 |a low molecular weight heparin 
650 4 |a pharmacokinetics 
700 1 |a Eschenfelder, Volker  |d 1941-  |e VerfasserIn  |0 (DE-588)1019037024  |0 (DE-627)690756372  |0 (DE-576)173058485  |4 aut 
700 1 |a Koderisch, Janti  |e VerfasserIn  |0 (DE-588)1304102750  |0 (DE-627)1860342884  |4 aut 
700 1 |a Weber, E.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Thrombosis research  |d Amsterdam [u.a.] : Elsevier Science, 1972  |g 73(1994), 2, Seite 95-108  |h Online-Ressource  |w (DE-627)30671082X  |w (DE-600)1500780-7  |w (DE-576)098253263  |x 1879-2472  |7 nnas  |a Pharmacokinetics of Clivarin a new low molecular weight heparin in healthy volunteers 
773 1 8 |g volume:73  |g year:1994  |g number:2  |g pages:95-108  |g extent:14  |a Pharmacokinetics of Clivarin a new low molecular weight heparin in healthy volunteers 
856 4 0 |u https://doi.org/10.1016/0049-3848(94)90084-1  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.sciencedirect.com/science/article/pii/0049384894900841  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20230927 
993 |a Article 
994 |a 1994 
998 |g 1304102750  |a Koderisch, Janti  |m 1304102750:Koderisch, Janti  |d 910000  |d 910100  |e 910000PK1304102750  |e 910100PK1304102750  |k 0/910000/  |k 1/910000/910100/  |p 3 
998 |g 1019037024  |a Eschenfelder, Volker  |m 1019037024:Eschenfelder, Volker  |d 910000  |d 910100  |d 50000  |e 910000PE1019037024  |e 910100PE1019037024  |e 50000PE1019037024  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 2 
998 |g 1076338119  |a Andrassy, Konrad  |m 1076338119:Andrassy, Konrad  |d 910000  |d 910100  |e 910000PA1076338119  |e 910100PA1076338119  |k 0/910000/  |k 1/910000/910100/  |p 1  |x j 
999 |a KXP-PPN1860342248  |e 4379459519 
BIB |a Y 
SER |a journal 
JSO |a {"title":[{"title_sort":"Pharmacokinetics of Clivarin a new low molecular weight heparin in healthy volunteers","title":"Pharmacokinetics of Clivarin a new low molecular weight heparin in healthy volunteers"}],"person":[{"given":"Konrad","family":"Andrassy","role":"aut","roleDisplay":"VerfasserIn","display":"Andrassy, Konrad"},{"family":"Eschenfelder","given":"Volker","display":"Eschenfelder, Volker","roleDisplay":"VerfasserIn","role":"aut"},{"role":"aut","display":"Koderisch, Janti","roleDisplay":"VerfasserIn","given":"Janti","family":"Koderisch"},{"roleDisplay":"VerfasserIn","display":"Weber, E.","role":"aut","family":"Weber","given":"E."}],"recId":"1860342248","language":["eng"],"note":["Elektronische Reproduktion der Druck-Ausgabe 9. April 2004","Gesehen am 27.09.2023"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"id":{"eki":["1860342248"],"doi":["10.1016/0049-3848(94)90084-1"]},"origin":[{"dateIssuedDisp":"1994","dateIssuedKey":"1994"}],"name":{"displayForm":["K. Andrassy, V. Eschenfelder, J. Koderisch, E. Weber"]},"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"publisherPlace":"Amsterdam [u.a.]","dateIssuedKey":"1972","publisher":"Elsevier Science","dateIssuedDisp":"1972-"}],"id":{"issn":["1879-2472"],"zdb":["1500780-7"],"eki":["30671082X"]},"type":{"media":"Online-Ressource","bibl":"periodical"},"note":["Gesehen am 15.11.23"],"disp":"Pharmacokinetics of Clivarin a new low molecular weight heparin in healthy volunteersThrombosis research","recId":"30671082X","language":["eng"],"pubHistory":["1.1972 -"],"part":{"text":"73(1994), 2, Seite 95-108","volume":"73","extent":"14","year":"1994","pages":"95-108","issue":"2"},"title":[{"title_sort":"Thrombosis research","title":"Thrombosis research","subtitle":"vascular obstruction, hemorrhage and hemostasis"}]}],"physDesc":[{"extent":"14 S."}]} 
SRT |a ANDRASSYKOPHARMACOKI1994